The AHA yesterday voiced support for the Competitive Health Insurance Reform Act (H.R. 1418/S. 350), legislation that would repeal the antitrust exemption available to commercial health insurers for anticompetitive conduct. “The AHA believes that the commercial health insurance industry should be governed by the same antitrust laws and policies that apply in other sectors of our economy, including hospitals and other health care providers,” AHA said in a letter to Sen. Steve Daines, R-Mont., and Rep. Peter DeFazio, D-Ore., the lead sponsors of the legislation. “Any exemptions should be narrow and carefully tailored to achieve a pro-competitive purpose. We have previously articulated our concerns to the Department of Justice’s Antitrust Division about the abuse of market power by large commercial insurers; this remains a concern as large commercial insurers continue attempts to consolidate to the detriment of consumers.”

Related News Articles

Headline
The House Energy and Commerce Subcommittee on Health Sept. 10 advanced the Title VIII Nursing Workforce Reauthorization Act (H.R. 3593), AHA-supported…
Headline
The House Appropriations Committee Sept. 9 advanced the fiscal year 2026 appropriations bill for the Departments of Labor, Health and Human Services, Education…
Headline
The AHA Sept. 8 urged the Federal Trade Commission and Antitrust Division of the Department of Justice to investigate several drug companies’ concerted efforts…
Perspective
Public
Congress returns to Washington, D.C., this week facing a long list of things to do, including several that will impact hospitals’ ability to provide access to…
Headline
The Department of Health and Human Services Sept. 4 announced new hardship exemption guidance that would allow consumers ineligible for premium tax credits or…
Headline
The AHA Sept. 4 expressed support for the Hospitals As Naloxone Distribution Sites Act (H.R. 5120), legislation that would require Medicare and Medicaid to…